MannKind to Present at Cantor Fitzgerald Global Healthcare Conference 2024

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD)Cantor Fitzgerald, Inc., a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and rare lung diseases, today announced that Chief Financial Officer Chris Prentiss and Dr. Wasim Fares Therapeutic Area Head, Orphan Lung Diseases, will share updates during an informal meeting at the Cantor Fitzgerald Global Healthcare Conference 2024 in New York.

The fireside chat will take place on Wednesday, September 18, beginning at 1:20 p.m. Eastern Time. A link to the live audio webcast of the session will be available on MannKind Corporation’s website at: https://investors.mannkindcorp.com/events-and-presentations. An archived, recorded version will also be available on the website for approximately 30 days following the call.